Subscribe To
Roche: lower guidance in 2023, but positive trajectory
Roche P/E is discounted vs its historical average. All in all, Roche maintained its growth path with sales up 1% to CHF 63.28 billion. Looking at the ...
February 2, 2023, 11:14 pm
Ihe: a top-heavy pharma etf that's more average than outstanding
IHE tracks the Dow Jones U.S. Select pharmaceuticals Total Return Index, which invests solely in U.S. <...
February 2, 2023, 6:07 pm
There's a crop of great biotech companies ready to be acquired, says mpm's christiana bardon
Dr. Christiana Bardon, co-managing partner of MPM's BioImpact Capital, joins 'The Exchange' to discuss tailwinds in the ...
February 2, 2023, 3:15 pm
Pharma earnings: covid βis highly uncertain for this year,' analyst says
Pharma Wells Fargo Managing Director Mohit Bansal joins Yahoo Finance Live anchors Rachelle Akuffo and Anjalee Khemlani to discuss ...
February 2, 2023, 2:36 pm
Biondvax presenting at bio ceo & investor conference
JERUSALEM, Feb. 02, 2023 (GLOBE NEWSWIRE) -- via InvestorWire β BiondVax pharmaceuticals Ltd . ( Nasd...
February 2, 2023, 2:15 pm
Reneo pharmaceuticals to participate in svb securities global biopharma conference
IRVINE, Calif., Feb. 02, 2023 (GLOBE NEWSWIRE) β Reneo pharmaceuticals, Inc. (NASDAQ: RPHM), a clinic...
February 2, 2023, 12:35 pm
Astrazeneca: will pharma giant beat revenue expectations?
AstraZeneca PLC (LSE:AZN) is poised to release its full-year results for 2022 on February 9, with shareholders hoping for the ...
February 2, 2023, 9:56 am
Eli lilly's stock falls after q4 revenue miss
Eli Lilly & Co.'s LLY, -0.46% stock fell 2.3% before market open Thursday after the biopharmaceutical g...
February 2, 2023, 7:18 am
Eli lilly stock falls even as earnings crush estimates
The pharmaceutical group reports earnings of $2.09 a share in the fourth quarter on revenue of $7.3 bil...
February 2, 2023, 7:03 am
Sage therapeutics to report fourth quarter and full year 2022 financial results on thursday, february 16, 2023
CAMBRIDGE, Mass.--( BUSINESS WIRE )--Sage Therapeutics, Inc. (Nasdaq: SAGE), a biopharmaceutical compan...
February 2, 2023, 6:30 am
West to host fourth-quarter and full-year 2022 conference call and announces participation in upcoming investor conferences
EXTON, Pa., Feb. 2, 2023 /PRNewswire/ -- West pharmaceutical Services, Inc. (NYSE: WST), a global leade...
February 2, 2023, 6:00 am
Time to buy cigna or regeneron stock before earnings?
Among the Finance and Medical sector, Cigna (CI) and Regeneron pharmaceuticals (REGN) are both leaders ...
February 1, 2023, 8:19 pm
Vanda pharmaceuticals to announce fourth quarter and full year 2022 financial results on february 8, 2023
Conference Call and Webcast to Follow WASHINGTON , Feb. 1, 2023 /PRNewswire/ -- Vanda pharmaceuticals I...
February 1, 2023, 6:30 pm
Blister and other high visibility packaging consumption snowballing owing to rapidly increasing usage in food industry: fact.mr report
The Global Blister And Other High Visibility Packaging Market Is Projected To Profit From The Rapidly Growing Food And ...
February 1, 2023, 3:30 pm
3 sorry pharma stocks to sell in february before it's too late
pharmaceutical stocks have been relatively subdued in the last 12 months. During this period, the S&P 5...
February 1, 2023, 1:55 pm
Onl therapeutics receives u.s. fda clearance of investigational new drug application for onl1204 ophthalmic solution
First-in-class small molecule Fas inhibitor with unique mechanism of action is designed to provide neuroprotection for retinal cells ANN ARBOR, Mich.,...
February 1, 2023, 12:00 pm
Respirerx pharmaceuticals' australian subsidiary inks loan agreements to advance r&d for sleep apnea treatment
RespireRx pharmaceuticals (OTC:RSPI) Inc announced that its recently created Australia-based subsidiary...
February 1, 2023, 9:41 am
Morphosys: negative enterprise value biotech, but lack of near-term catalyst
MorphoSys AG is a German commercial-stage biopharmaceutical company founded in 1992 with more than 100+...
February 1, 2023, 9:21 am
Zentalis pharmaceuticals to participate in two upcoming investor conferences
NEW YORK and SAN DIEGO, Feb. 01, 2023 (GLOBE NEWSWIRE) -- Zentalis pharmaceuticals, Inc. (Nasdaq: ZNTL)...
February 1, 2023, 7:01 am
Novo nordisk lifts dividend, launches $4.09 billion share buyback after earnings beat forecasts
Danish pharmaceutical company Novo Nordisk AS DK:NOVO.B NVO on Wednesday raised its dividend and launch...
February 1, 2023, 2:25 am